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The success of anti-TNF agents, as well
as the more recent outburst of highly
effective biologics targeting the IL-23/IL-
17 axis, should not overshadow the fact
that there is still a sizable number of
nonresponder patients who might
benefit by an alternative strategy.
The mouse model described by
Gunderson et al. (2013) uncovers
an important aspect of CD8 T-cell
pathogenicity in skin inflammation
mediated by IFN-g, while posing new
critical questions. Answering them will
enhance our understanding of the
pathological mechanisms underlying
psoriasis and could ultimately lead to
novel effective therapeutic strategies.
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Toll-Like Receptors Link Atopic March
to the Hygiene Hypothesis
Lajos Keme´ny1,2 and Korne´lia Szabo´1
In recent decades, the prevalence of atopic diseases has increased substantially
worldwide, but their molecular pathologies are now being elucidated. The report
by Haapakoski et al. in this issue suggests that the manner in which the immune
system encounters an allergen is key to the subsequent polarization of its
responses, and the presence of microbial ligands appears to be important in this
process. Data in this report provide further proof of the hygiene hypothesis that
combine it with known features of the atopic march.
Journal of Investigative Dermatology (2013) 133, 874–878. doi:10.1038/jid.2013.11
The hygiene hypothesis was first intro-
duced in 1989 by David P Strachan,
who proposed, based on epidemiological
studies, that changes in personal hygiene,
improvements in household amenities,
and declining family sizes had been
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accompanied by enormous increases in
the prevalence of atopic diseases, includ-
ing hay fever, eczema, and asthma,
especially after the industrial revolution.
He claimed that infections early in child-
hood could be beneficial and may lead to
protection against these diseases later in
life. The implication was that the rising
living and personal standards and the
currently popular small family sizes
would in some way act against correct
development of immunity (Strachan,
1989). Since then, many epidemio-
logical studies have established a clear
relationship between the marked changes
that parallel adoption of a ’’western’’ life-
style, with an increasing incidence of
atopic diseases. Even within a given
country, where individual genetic,
environmental, and climatic conditions
are similar, clear differences have been
reported in the proportions of children
that develop these diseases in large cities
as compared with the countryside (Ege
et al., 2011). Various factors associated
with industrialized and urban living
have been studied extensively and, in
addition to effects of environmental
microbes, personal microbiomes too
have recently been suggested to have an
important role (Heederik and von Mutius,
2012).
Since their first publication, Stra-
chan’s ideas have created considerable
controversy in the scientific community.
When his hygiene hypothesis was intro-
duced, there was no clear-cut explana-
tion for the observations. Later, the Th1/
Th2 model of immune regulation led
to mechanistic explanations for how
the hygiene hypothesis might operate.
It was suggested that contact with an
environmental allergen leads to acti-
vation of the innate immunity, with
uptake and activation of antigen-
presenting cells resulting in activation
of CD4þ T cells. In atopic individuals,
this was polarized toward Th2 cells that
secrete IL-4, IL-5, and IL-13, subse-
quently stimulating IgE antibody pro-
duction by B cells and increased
numbers of mastocytes and eosinophils.
This would contrast with events in
‘‘healthy’’ individuals in whom T cells
exhibit a Th1-like profile in response
to the same challenge. Taken together,
this raised the possibility of differences
in the childhood programming of
immunological memory, although how
this was achieved remained unknown
(reviewed by Holt et al., 1999;
Yazdanbakhsh et al., 2002). A combi-
nation of the hygiene hypothesis with
contemporary results, however, led to
the assumption that early training of the
immune system might occur through
contact with pathogenic microbes,
or alternatively through effects of com-
mensal microflora (or both), thus
strengthening the Th1 arm of the
defense. In the western lifestyle, such
encounters would be less common, and
in urbanized environments a shift
toward Th2 responses would lead to
the development of atopy (Frei et al.,
2012; Heederik and von Mutius, 2012;
Hanski et al., 2012). Nonetheless, little
was known about how this might
happen at molecular levels.
The atopic march
Early models to explain the pathogen-
esis of atopic diseases after the intro-
duction of the hygiene hypothesis
concentrated on the role of the adaptive
immunity, and within the Th1/Th2
immune paradigm. Molecular and
genetic studies, however, raised the
possibility that the primary defect might
actually lie in the skin. This was based
on the observation that atopic dermati-
tis (atopic eczema), a chronic pruritic
skin condition commonly occurring
early in life, might be considered a
major risk factor for the subsequent
development of more severe atopic
diseases, such as allergic rhinitis and
asthma. This concept of a continuous
development of atopic diseases from
atopic dermatitis through allergic rhini-
tis, to allergic asthma, named the atopic
march, raised the possibility of a well-
defined pathogenic route beginning in
the skin, all the way to airways (Spergel,
2005; Zheng et al., 2011).
Barrier defects in the development of
atopic disorders
Barrier defects are key early factors in
the development of atopic dermatitis
and the subsequent atopic march, and
one of the early steps in this process is
an enhancement of allergic sensitiza-
tion, which occurs through the frequent
epidermal injuries that characterize
atopic skin. This concept was corrobo-
rated in experimental animal studies,
which demonstrated that transcutaneous
immunization with an allergen follo-
wed by airway challenge is capable of
inducing airway hyper-responsiveness
and enhanced mucus production, two
features of allergic asthma (Lehto et al.,
2005).
The importance of a healthy cuta-
neous barrier was also shown in genetic
studies that demonstrated variations of
the filaggrin gene, which were not only
important in the formation and main-
tenance of an intact barrier, but would
also have important roles in the predis-
position to atopic diseases (Heimall and
Spergel, 2012; Kubo et al., 2012).
Toll-like receptors and the hygiene
hypothesis
In the second half of the 1990s, discov-
ery of the prototype of pathogen
recognition receptors, the mammalian
Toll-like receptors (TLRs), followed by
acquisition of an enormous amount of
information, led to new models to
Clinical Implications
 Cutaneous sensitization is an important route for initiation and develop-
ment of the atopic march in genetically predisposed individuals.
Microbe-derived molecules and the Toll-like receptor (TLR)-dependent
activation of the innate immunity contribute to the shaping of adaptive
immune responses. When this occurs in parallel with allergenic sensitiza-
tion through the cutaneous route, they can modify the outcome by
inducing Th1 responses and subsequently inhibiting Th2 responses.
 Immune-based therapeutic strategies involving the use of antigens
together with TLR ligands and a cutaneous route of immunization may
lead to the prevention of atopic sensitization.
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explain details of hygiene hypothesis
at a molecular level. It was suggested
that early immune ‘‘training’’ is
achieved through repeated activation
of certain TLRs by binding and recogni-
tion of conserved pathogenic or micro-
bial molecules (pathogenic molecular
patterns or microbial molecular pat-
terns). The resulting initiation of innate
immune responses was found to have
important roles in the shaping of adap-
tive immune events (Iwasaki and
Medzhitov, 2010).
Recognition that childhood microbial
challenge was important in the devel-
opment of balanced immunity suggested
that pathogen recognition receptors and
the signaling events they initiated were
important. TLRs have been shown
to be expressed by keratinocytes
(Pivarcsi et al., 2003) and it therefore
seemed possible that they would
participate in the regulation of early
innate immune events and, in parallel,
in the initiation and development of
the atopic march. However, clear-cut
experimental evidence proving roles or
even the existence of such mechanisms
was lacking.
Independent confirmation of this con-
cept was provided by genetic studies,
which indicated that, in addition to the
role of filaggrin mutations, various poly-
morphisms in genes having important
roles in microbial recognition and
downstream signaling also contributed
to genetic susceptibilities to atopic
diseases. In this context, the roles
of pathogen recognition receptor poly-
morphisms have been investigated.
Genetic case–control analyses have
pointed to associations among poly-
morphisms of TLR2, TLR4, TLR6,
TLR10, and CD14 in some studies, but
other studies did not confirm these
findings (Yang et al., 2006). The
reasons for this are not yet known, but
population differences and variabilities
in experimental conditions might
well be responsible. Alternatively,
gene–environment interactions may also
vary greatly in different populations,
thereby modifying the results. Never-
theless, it may be concluded that geneti-
cally determined differences in the
regulation of innate immune responses
to microbial ligands do have roles in the
development of atopic diseases.
Experimental demonstration of the role of
microbial recognition in the pathogenesis
of allergic asthma
In a paper in the current issue of JID,
Haapakoski et al. (2013) modeled the
development of allergic asthma using a
natural route of cutaneous sensitization.
They applied ovalbumin as an experi-
mental antigen on tape-stripped skin of
mice, alone or together with various
TLR2, TLR3, and TLR4 ligands (Pam3
Cys, Poly(I:C), and lipopolysaccharide,
respectively), and assayed the modifying
effect of TLR activation on selected
molecular, cellular, biochemical, and
clinical parameters of the disease.
Exposure to lipopolysaccharide, and to
a certain extent also to Pam3Cys, was
observed to cause a significant reduc-
tion in the production of Th2 cytokines
such as IL-4, IL-5, and IL-13 in the lung,
and IL-13 in draining lymph nodes. At
the same time, the extent of inflamma-
tory infiltrate, and specifically the
number of eosinophils in the bronch-
oalveolar lavage fluid, was decreased,
and the number of periodic acid–Schiff-
positive cells was similarly reduced by
these microbial ligands. Interestingly,
in contrast with currently accepted
models, unchanged or reduced FoxP3
mRNA levels in the lungs of mice
treated with ovalbumin together with
Pam3Cys and lipopolysaccharide,
respectively, suggested that these effects
were not the consequence of induced
regulatory T cells. The protective effects
were not due to TLR tolerance either,
but were completely dependent on the
induction of IFN-g in the lung.
Can signaling differences downstream of
various TLR receptors account for the
effects of diverse ligands?
The evidence had suggested that not all
TLR ligands would function equally in
the model described above. Whether
this is limited to mice, whether
dose-dependent differences exist when
various TLR ligands are applied, and
whether the answers lie somewhere else
remain important questions. However,
the evidence suggests that signaling
events downstream of the TLR2 and
TLR4 ligands operate similarly and these
ligands exhibit comparable, protective
effects in the given experimental setting.
This contrasts with results obtained
using the TLR3 ligand Pam3Cys, which
is mostly ineffective at low doses, but
which in large quantities even exerts a
Th2-augmenting effect. Interestingly,
TLR3 is the receptor that induces alter-
native downstream signaling pathways
that function through the TIR-domain-
containing adapter-inducing interferon-
b protein instead of the canonical
MyD88-dependent mechanisms utilized
by TLR2 and TLR4 (Takeda and Akira,
2004; Akira et al., 2006).
A proposed mechanism for TLR2,
TLR4-mediated allergic asthma protection
These results and the current models
now suggest that an important aspect
in the early ‘‘training’’ of immune
responses is the context in which anti-
gens are introduced. If introduced
together with pathogenic molecular pat-
terns or microbial molecular patterns
that have the ability to activate specific
pathogen recognition receptors, will
these antigens be treated as molecules
of microbial origin? Thus, non-atopic
individuals react differently to a novel
allergen. The results of Haapakoski et al.
(2013) combined with the hygiene
hypothesis further suggest that, if envi-
ronmental and/or commensal symbiotic
microbial flora that colonize the various
body parts are reduced during the early
development of immunity, some anti-
gens will be introduced without costi-
mulatory activities of the microbial TLR
ligands. As a result, repeated encounters
with the same antigen will gradually
lead to an excessive Th2 response, with
the development of more severe forms
of atopic disease, i.e., the atopic march
(Figure 1; Holt et al., 1999). This would
explain, in part, the important question
of how and why different response
patterns are programmed in the
immunological memories of different
individuals.
If the above theory holds true, why do
some individuals who live a natural
lifestyle, surrounded by animals, still
develop atopic diseases, and why does
not everyone who lives in an urbanized
environment suffer from these diseases?
Moreover, numerous children who con-
tract atopic dermatitis in their early life
do not go on to develop allergic rhinitis
or asthma. These answers may also lie
in each individual’s genetic constitution,
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reflecting the true multifactorial nature
of these diseases.
Contradictory data suggesting the
Th2-promoting role of TLR ligands during
allergenic sensitization
The scientific community does not
entirely welcome the ideas concerning
the protective role of microbial ligands
in the pathogenesis of atopic diseases.
Opponents also base their ideas on
experimental data acquired from similar
mouse models. In fact, other evidence
favors the conclusion that microbial
ligands may enhance the development
of asthma (reviewed by Schroder and
Maurer, 2007). Direct comparisons of
results is difficult; however, differences
in experimental protocols involving
routes and doses of TLR ligands and
the genetic backgrounds of the mouse
strains used may be responsible. The
data appear to suggest that the dose and
the exact circumstances under which
the body meets the allergens really are
crucial. To date, TLR9 seems to be the
only ligand that repeatedly promotes
Th1 differentiation, somewhat indepen-
dently of the sensitization method used.
In contrast, when applied together with
ovalbumin through the airways or
injected intraperitoneally, lipopolysac-
charide, a relatively strong Th1-promo-
ting agent, tends to preferentially induce
Th2 skewing of the immune events
(Schroder and Maurer, 2007).
Significance and clinical consequences of
the novel observations
The novel observations made by
Haapakoski et al. (2013) will facilitate
our understanding of the molecular
mechanisms involved in the early steps
of allergic sensitization. Their work pro-
vides experimental confirmation of the
importance of cutaneous sensitization in
the development of allergic asthma in
atopic patients, and it suggests why and
how similar processes may lead to protec-
tion in individuals who are not predis-
posed to the development of atopic
disorders. Haapakoski et al. (2013) addi-
tionally provide clear-cut experimental
evidence about how microbe-derived
molecules and the activation of the
innate immune system contribute to the
shaping of adaptive immune responses.
Naturally, certain limitations must
also be borne in mind. Differences
in the immune responses between
mice and humans demand care when
extrapolations are made. Again, although
ovalbumin is the most widely studied
allergen, it is not the strongest Th2 inducer
and lacks the intrinsic enzymatic (e.g.,
protease) activities possessed by most
natural allergens (Schroder and Maurer,
2007). What emerges from these and
similar studies, in combination with the
large amount of epidemiological and
clinical data currently available? First,
it is important that parents and health-
care professionals (especially pediatri-
cians, dermatologists, pulmonologists,
and immunologists) should be fully
aware of the importance of the early
programming of the immune system and
the crucial role of microbial ligands from
the environment. A little ‘‘dirt’’ may well
be beneficial for balanced development of
the body’s immunological defense, and
children should come into contact with a
sufficient number and various types of
microbial molecules during early life to
acquire a mature, balanced level of
protection. Ideas have been put forward
about how genetically susceptible indivi-
duals (e.g., carriers of certain filaggrin
alleles, or children with a family history
of severe atopic disorders) may be
‘‘trained’’ to react more appropriately to
various environmental allergens. Ob-
viously, there is still a long way to go
and more experimental evidence is
required for the development of such
immunomodulatory interventions. The
recent results, however, are an important
advance toward therapeutic modalities
that may be preventive, rather than
strictly therapeutic.
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BRAF and MC1R in Melanoma:
Different in Head and Neck Tumors?
Emma C. Fink1 and David E. Fisher1
In this issue, Hacker et al. (2013) report the largest study to date on the association
between MC1R variants and BRAF mutant melanoma. Although they did not
observe a significant overall correlation, there was a significant negative
association between BRAF and MC1R mutations for head/neck melanomas. This
suggests a fundamental difference in pathogenesis between head/neck and
truncal melanomas, which could contribute to their divergent prognoses.
Journal of Investigative Dermatology (2013) 133, 878–880. doi:10.1038/jid.2012.475
Cutaneous melanoma arises from com-
plex interactions among genetic and
environmental factors. Epidemiological
and molecular evidence indicates that
these interactions may influence not only
the incidence of melanomas but also
their fundamental pathogenic mechan-
isms. A high fraction of cutaneous mela-
nomas have acquired somatic mutations
in BRAF or NRAS, but these muta-
tions are generally mutually exclu-
sive. Mutations in both BRAF and NRAS
lead to extracellular signal–regulated
kinase activation, enhancing prolifera-
tion, survival, and invasion (Thomas,
2006). However, the presence of signi-
ficant gene expression and signaling-
related differences suggests that BRAF
and NRAS mutations utilize at least
partially distinct mechanisms of melano-
genesis (Bloethner et al., 2005).
BRAF is a serine/threonine kinase
involved in the Ras–RAF–mitogen-acti-
vated protein kinase pathway. Mutations
See related article on pg 1027
in BRAF are found in approximately
50% of cutaneous melanomas, most
often those that arise on intermittently
sun-exposed skin in relatively young
patients (Thomas, 2006; Tsao et al.,
2012). Although over 30 different
BRAF mutations have been reported,
one mutation, BRAF V600E, is by far
the most common. Although UV
exposure is a major risk factor for
melanoma, BRAF V600E is due to an
T-A transversion, rather than the more
commonly UV-associated C-T
transition (Brash, 1997; Tsao et al.,
2012). Some have suggested that
selection of rare UV-induced C-T
transitions could explain this
observation; others posit that the
reactive oxygen species (ROS)
generated as a by-product of melanin
synthesis are a more likely culprit
(Thomas, 2006).
Melanoma risk is strongly tied to
pigmentation, a key determinant of
which is MC1R. MC1R is an as-type G
protein–coupled receptor, which is
found on melanocytes and which
responds to a-melanocyte-stimulating
hormone. MC1R is highly polymorphic
in Caucasians with over 60 variants,
classified as partial loss of function
(r alleles) or complete loss of function
(R alleles) (Garcia-Borron et al., 2005;
Tsao et al., 2012). Polymorphisms in
MC1R contribute to the phenotypic
spectrum of freckling and hair and skin
coloration (particularly red hair), but
have also been suggested to modulate
melanoma risk independent of
pigmentation. Cells expressing MC1R
variants have higher levels of ROS,
which could potentially contribute to
ROS-related BRAF mutations (Thomas,
2006; Tsao et al., 2012). Our group
recently demonstrated a UV-
independent increase in oxidative lipid
and DNA damage in a ‘‘redhead’’
mouse model with inactive MC1R.
Expression of BRAF V600E in this
model led to an increased risk of
invasive melanoma in the absence of
providing secondary mutations or UV
exposure. Both oxidative damage and
melanoma development were abrogated
when pigment production was blocked
by an albino allele, suggesting that
pheomelanin production is key to
these phenotypes (Mitra et al., 2012).
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